To this end, we generated HDGFRP3 knockout (KO) cells by CRISPR/Cas9 in MDA-MB-231 breast cancer (Figure 3C) and ES2 ovarian cancer cells (Figure 3D). This evidence concerns the gene HDGFL3 and ovarian carcinoma.